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"Tell me what they do to my body": A survey to find out what 
information people with learning disabilities want with their 
medications 
Dr Rebecca Fish, Centre for Disability Research, Department of Sociology, Lancaster University, UK 
Prof Chris Hatton, Centre for Disability Research, Faculty of Health and Medicine, Lancaster 
University, UK.  
Dr Umesh Chauhan, Medical School, University of Central Lancashire, Preston, UK 
Accessible Summary 
 We gave a questionnaire to self-advocates who were attending a conference. The 
questionnaire asked them how they felt about the information they get with their medicine. 
 Fifty eight people completed the questionnaire. Many of them said they did not get enough 
information about their medicine. Most people wanted easy-read leaflets and pictures. 
 There are many different places to find easy-read information on the internet. We think they 
should be collected and checked. We also think that doctors and chemists need to spend 
more time with people to explain about medicines. 
Abstract 
Background: Previous research has found that people with learning disabilities are not given 
prescription information that is tailored to their needs. We wanted to find out people’s information 
requirements. 
Materials and Methods: A questionnaire was co-produced by the authors and consultants with 
learning disabilities. It asked them what information people received from their GP and pharmacist 
about medications. The questionnaire was circulated at a self-advocacy conference in the North of 
England. Fifty eight self-advocates completed the questionnaire.   
Results: Information from GPs and pharmacists was mainly instructional, referring to when and how 
to take the medicine and dosage. Most respondents struggled to read the leaflets and remember 
verbal information. Many wanted the information in easy-read format, and some wanted pictures or 
diagrams as well.  A key theme was that health professionals often talked only to carers or support 
workers rather than involving the patient directly, and some disclosed that they were not informed 
about side effects or alternative medications.  
Conclusions:  Health professionals should take time to discuss health issues and medication with the 
individual rather than only with carers. This could be facilitated by providing information in an 
accessible format. 
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Introduction 
There are clear health disparities between people with learning disabilities and the general 
population (Heslop et al., 2014, Emerson and Hatton, 2013), leading to concern among professionals 
about the health information they provide. People with learning disabilities are prescribed 
medication for psychological and medical conditions as well as for the reduction of challenging 
behaviour (Lewis et al., 2002). They experience higher rates of adverse health conditions such as 
epilepsy and neurological disorders, gastrointestinal disorders and psychiatric conditions as well as 
higher levels of preventable health issues (Krahn et al., 2006). Some of this disparity may be because 
they are not getting the correct information about medication, healthy living or self-screening (Krahn 
et al., 2006), and furthermore they may experience poorer access to quality primary care due to lack 
of reasonable adjustments which take into account people’s needs (Balogh et al., 2010, Alborz et al., 
2005).  
It has been found that education level and cognitive functions such as memory and 
conceptualisation are related to medication compliance in psychiatric services (Ruscher et al., 1997, 
Jeste et al., 2003). Often, ‘health literacy’ of patients is referred to as the problem (Wolf et al., 2006), 
however it has been argued that this can be addressed by reducing the use of jargon and 
understanding the communication needs of patients (Shepard, 2016). 
In a review of the literature about medication/prescription information and the perspectives of 
people with learning disabilities, we found a small number of research studies.  Among them were 
Arscott et al (2000), who interviewed 30 people with learning disabilities about their medication. 
They found that 70% of adults with learning disabilities took psychotropic medication, 66.7% took 
non psychotropic medication and 26.6% of their participants were prescribed 4 or more medications 
regularly. In terms of information, they found that their participants had limited knowledge about 
side-effects, alternatives to the medicine they were taking and contra-indications. Arscott et al argue 
that people are not given enough information about their medicine, and that information is not 
accessible enough. 
Heslop et al. (2005) found their participants to be similarly ill-informed. They interviewed 21 people 
with learning disabilities, their carers and prescribers. They found that few people were fully advised 
about why they were taking their medication and the potential adverse effects. Most of the 
information had been given to carers, who knew how to administer medicines but did not know why 
they had been prescribed or the implications. People felt that they had little or no choice about 
taking the medication. Heslop et al recommended that prescribers spend time to explain key facts 
and provide accessible and up-to-date information which is tailored to the patient’s needs, and that 
training should be provided for carers. 
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A key theme in the literature is that people were given inappropriate information not tailored to 
their needs. For example, a National Patient Safety Agency (2004) study with 45 participants with 
learning disabilities found that medication information was inaccessible; the participants in this 
study would have preferred information with pictures or in an audio format. People said that they 
often identified their tablets by colour, something that was flagged up in the report as potentially 
dangerous, as different pills can look similar to each other and a medication’s appearance can 
change over time.  
Research has found that people with learning disabilities also lack knowledge about psychotropic 
medications that they are prescribed. For example, Strydom et al. (2001) gave a questionnaire to 21 
people with learning disabilities who were prescribed antipsychotic medication; 22% did not know 
why they were taking the medication, 48% could not read the label, 38% did not know any side 
effects, and 52% were not aware of any contraindications. Twenty people said they would have liked 
a readable leaflet. Participants wanted more information about indications, contra-indications and 
side effects. Strydom et al suggest that people with learning disabilities are unlikely to seek 
information about their medications and it is therefore the responsibility of health professionals to 
make such information readily available and understandable.  Even if people with learning 
disabilities do possess adequate information, they may experience difficulties in communicating 
side-effects of their medication and may find it hard to report adverse effects such as blurred vision 
or feeling dizzy. 
Research investigating pharmacist services reveals some of the information barriers. The Disability 
Partnership (2016) gathered in-depth questionnaire data about medication and pharmacy visits from 
103 people with learning disabilities. They found that respondents visited their pharmacist once a 
month on average and 30% wanted their pharmacist to be more patient. Fifteen percent of 
respondents stated that they did not know why they took their medication. They conclude that a 
number of barriers to positive experiences exist, such as access to information, clear communication 
and explanation of the purpose of medicines. They advise that there is significant room for 
improvement in order to make pharmacy services for disabled people an empowering experience in 
relation to managing their health.  
Similarly, Jubraj et al (2016b) explored people’s experiences of pharmacies in a focus group with 
people with learning disabilities. They found that the focus group members in their study, despite 
regularly taking medicines, were unclear about why they needed them and how they helped. They 
explained that pharmacists often spoke to their parents or carers during consultations instead of 
them. All were unaware that they could ask the pharmacist themselves for information about their 
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medicines. Group members said they would like the pharmacist to talk to them directly and give 
them more accessible information about their medicines.  
This existing literature shows that people with learning disabilities are not getting enough 
information about their medication from either their GP or pharmacists. In particular, more 
information is needed about the function of the medicine as well as risk factors and 
contraindications. Furthermore, health professionals are not involving patients themselves in 
consultations enough, preferring to discuss with carers or family members. Health outcomes are 
better when patients take a more participatory role in decisions about their health (Trummer et al., 
2006), but without making sure that patients have the correct knowledge to make decisions, it is 
impossible to assume their consent to treatment.  
Each of the studies outlined above focusses on a particular area of prescribing. None of the studies 
asks participants where they get the most helpful information from and what format they would 
prefer. This research study aimed to explore these questions using a small-scale questionnaire study. 
Policy 
There are important national guidelines in the UK on how communication should occur with people 
with learning disabilities.  The Mental Health Act (1983) makes it clear that people should be 
informed about side effects of medication as well as alternatives. Further, NICE guidance (2012, 
2009) mentions consent, capacity and decision-making, advising that professionals should assess the 
person's capacity to make decisions throughout assessment, care and treatment for any health 
problem on a decision-by-decision basis, in accordance with the Mental Capacity Act (2005).  People 
should be helped to decisions by ensuring that their communication needs are met and (if 
appropriate) involving a family member, carer, care worker or other individual familiar with the 
person's communication abilities. The requirement for service providers to make “reasonable 
adjustments” to their provision, including information they offer about their services, is included in 
the 2010 Equality Act (Equality Act, 2010). 
The NHS England Accessible Information Standard (2016) came into force in England on 31st July 
2016. The Standard specifies that it is the responsibility of services to make understandable 
information available to everyone. The principles for health services are as follows: 
1. Ask: find out if an individual has any communication or information needs relating to an 
impairment or sensory loss and if so what they are. This must be done ‘proactively and 
opportunistically’ using professional judgment. This may include using guidance questions to 
find out about any learning disability, as detailed in Glover and Emerson (2012). 
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2. Record: record those needs in a clear, unambiguous and standardised way in electronic and 
/ or paper based record. Information needs should be recorded rather than impairment or 
condition. 
3. Alert / flag / highlight: ensure that recorded needs are ‘highly visible’ whenever the 
individual’s record is accessed, and prompt for action.  
4. Share: include information about individuals’ information or communication needs as part of 
existing data sharing processes (and in line with existing information governance 
frameworks).  
5. Act: take steps to ensure that individuals receive information which they can access and 
understand, and receive communication support if they need it.  
Although this act only relates to England, it should be considered good practice for all health 
providers to follow this guidance. The Equality Act (UK) and the Accessible Information Standard 
make it clear that it is the responsibility of the organisation and its staff to make information 
understandable in order that patients make informed decisions about their care. 
It is envisaged that the findings from the present study will be helpful to services when they are 
planning how to implement these policy goals, in terms of people’s information requirements and 
the format of resources to use. 
Method 
This study was funded by East Lancashire Clinical Commissioning Group (CCG).  Ethical approval was 
granted by the ethics committee at Lancaster University Faculty of Health and Medicine and was 
determined to be service evaluation/improvement by the NHS Research Ethics Committee. The aim 
of the study was to gauge the level of information currently being provided, and the requirements of 
people with learning disabilities for more information related to their medication. The research 
questions for this study were: 
1. What prescription and medication information do people with learning disabilities currently 
receive from their GP?  
2. What information do they receive from their pharmacist? 
3. How helpful is this information? 
4. What other information is required and how should it be presented? 
The researchers collaborated with the North West Training and Development Team (NWTDT) and 
Pathways Associates to discuss the research questions with them. NWTDT and Pathways Associates 
are not for profit organisations who work with self-advocacy group members to provide consultancy 
services. They discussed the research objectives with their consultant members and the researchers 
6 
 
and created an easy-read questionnaire that asked the following questions (accompanied by 
pictures): 
 What information are you given when you get medicine from the doctor? 
 Is it useful? 
 What else could the doctor do to help you understand your medicine? 
 What information are you given when you get your medicine from the chemist? 
 What other support would help people to understand their medicine? 
The pictures were simple, line drawn black and white, depicting people and objects such as medicine 
bottles and pill blister packs. 
This questionnaire was circulated to all self-advocates at the North West Self-Advocacy conference 
which was held in Blackpool in February 2016 and is organised by NWTDT and Pathways Associates. 
The delegates were asked to complete the questionnaires alone or with support from their assistant 
or family members.   
Fifty eight questionnaires were returned. This represents approximately 48% of the 120 self-
advocates who attended the conference. This may have some relevance to the type of data 
obtained; perhaps only those who were above a particular threshold of literacy agreed to complete 
a questionnaire.  The questionnaires were anonymous, no names were collected or recorded. 
The results were organised into themes, with a frequency count to show how many responses 
reported the same issue. In the results section below, we use tables to show the frequency count 
and provide an example quote to illustrate the theme. 
Results 
From the questionnaire responses, it was clear that people had experience of visiting and obtaining 
medications from both GP surgeries and pharmacists. Most of the questionnaires were fully 
completed and people often provided multiple points in each section. Each of the following tables 
shows the groups of responses and the amount received. Example comments from the completed 
questionnaires are provided. 
Fifty five percent of people (n=32) said that they got helpful information from their GP; Table 1 
shows in more detail what information they received.  Out of those who answered that the 
information was helpful, most of the information they received was instructional, such as when to 
take the medicine and for how long.  Some of these participants reported that their GP took time to 
explain about the medicine and show them how to take it. 
Table 1: Helpful information received from GP 
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Response Frequency Example comment 
When to take medicine / how often / 
for how long  
11 ‘3 Times daily, for asthma. Written and 
verbal.’ 
Took time to explain about medicine 
/ answered questions  
7 ‘Told everything about my medicine. Does 
explain to me.’ 
What the medicine is called  5 ‘What the medicine is called and what it is 
used for.’ 
What the medicine is used for  4 ‘I have a good doctor who will tell me what 
the medicine is for and will answer any 
questions I have.’ 
How the medicine works and what it 
does  
4 ‘My doctor tells me statins are for my 
cholesterol.’ 
How to take the medicine 3 ‘Just to take my inhalers, brown one twice 
in the morning and night, blue one when 
I’m wheezing.’ 
When to get next prescription  2 ‘They tell me when to pick my next 
prescription up and what they are for.’ 
Showed me how to take it  2 ‘Showed how to use the medication. Tested 
condition for a while then diagnosed. 
Verbal.’ 
Dosage  2 ‘The information you are given is the sort of 
tablets they put you on and how many 
times a day to take them.’ 
 
Overall 29% of participants (n=17) said the information they received was not helpful. Table 2 shows 
the reasons people gave for this. The most frequent themes were that the information was not 
accessible to them and they were only given basic information. Some people reported that 
information was only given to their carer and they were not involved in the discussions. 
Table 2: Reasons why information given by GP is not helpful 
Response Frequency Example comment 
I can’t read or write / writing too 
small and no pictures   
4 ‘He gives us the medicine. I can’t read or 
write so then don’t understand what’s on it. 
He sometimes tells me but I don’t always 
remember what’s been said so ask friends 
or People First.’ 
I am only told when to take it / how 
to take it  
4 ‘How to take it and for how long. If no 
better come back in two weeks.’ 
Just  verbal instructions  3 ‘Not much write the prescription out. 
Doctor says how often to take it.’ 
Only told what the medicine is 
called  
2 ‘Just what I take.’ 
Instructions are given to my carer  2 ‘It’s given to my dad not me.’ 
No information given  2 ‘I just get a prescription.’ 
 
Table 3 shows what information people said they received from their pharmacist.  Twenty four 
percent of respondents (n=14) reported receiving no information at all.  The information people 
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reportedly received was instructional, such as dosage and when to take the medicine.  Five 
respondents reported that the pharmacist gave information to their carer but not to them.  Some 
people reported that the information was not accessible or was given verbally only. 
Table 3: Information received from pharmacist 
Response Frequency 
No information 14 
Paper Information  
 Dosage  8 
 Inaccessible leaflet  8 
 When / how often to take medicine  7 
 Different names for the same medicine is confusing 2 
 How to store the medicine  1 
 Given a phone number  1 
Face-to-face  
 Given verbal information  4 
 When to come back / how long medicine will last  3 
 How to take medicine  3 
 Mentioned a side-effect 1 
Other  
 They speak to my carer not to me  5 
 Information is on computer, not accessible to me  2 
 
Table 4 shows all the suggestions that people gave for change, incorporating the answers to both 
questions: ‘What else could the doctor do to help you understand your medicine?’ And ‘What other 
support would help people to understand their medicine?’  Sixty six percent of people (n=38) 
wanted an easy read leaflet and 17% (n=10) wanted pictures or diagrams. Seven percent (n=4) 
reported that they wanted information about side effects and risks so they could make a choice 
about different medicines.  Some participants stated that they wanted their carers or family to be 
involved, but would prefer that the health professionals discussed the issues with them as the 
patient. 
Table 4: suggestions for change 
Response  Frequency Example 
Paper Information   
 Large print / easy read with 
no jargon / greater detail  
38 ‘Information that’s easy to understand for 
everyone. Large print easy read instructions. 
Pictures.’ 
 Pictures / diagrams  10 ‘Talk to me easier. Giving me pictures of 
when to take the tablets e.g. picture of sun 
= sunrise am x 2 tablets. Give me easy read 
info about what it is for.’ 
 Safety info / how not to 
overdose / what happens if 
not taken  
6 ‘Could help to understand what may 
happen if not taken or more than dose 
taken, to help you.’ 
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 Information about side 
effects / risks  
4 ‘Actually explain why you are taking it and 
what it does and what it is for. Say what I 
might expect (side effects).’ 
 Photos / videos of how to 
take it  
3 ‘Written down info and video on how to 
take it.’ 
 Telephone helpline 2 ‘A telephone helpline with simple audio 
information about medicine and what it 
does.’ 
 Information about how to 
look after ourselves to avoid 
medicine  
1 ‘How to look after ourselves so we don’t 
have to use our medicine for a long time / 
reduce amount.’ 
Face-to-face   
 Listen to patient / take time 
to explain and answer 
questions  
11 ‘I get upset. The doctor needs to slow down 
and tell me what is happening. Then I will 
feel better.’ 
 Support workers / families 
involved and informed  
10 ‘Support worker/parent explaining again 
about meds in a comfortable relaxed 
environment and ask if any questions.’ 
 Verbal explanations with no 
difficult words  
9 ‘Any info in a verbal equivalent of easy read, 
plain English would help.’ 
 Explain why I need to take it  8 ‘Easy read and simple explanation (needs to 
be written down, I don’t always get it when 
they just say it). What I need to take, when I 
need to take it and why I am taking it.’ 
 Explain how the medicine 
works  
5 ‘To talk about it a bit longer. Tell me what 
they do to my body.’ 
 Aids such as hearing loop / 
braille / sign language / 
interpreter  
5 ‘If you are buying medicine over the counter 
for a cold or diarrhoea if you need this they 
could explain what medicine is best for you 
they could also have a hearing loop for deaf 
people or provide braille for people with 
poor sight.’ 
 Talk to patient rather than 
support / carers  
4 ‘Make words bigger and easy-read. Spend 
time explaining things to me and not the 
support.’ 
 Explain about alternative 
medicines 
3 ‘Give me an easy read information sheet: is 
there something else I can take instead?’ 
Other   
 Regular reviews and health 
checks  
5 ‘Your doctor could tell you why you need 
your medication. He could send you for a 
medical review and take blood tests.’ 
 Mobile alerts / special alarm 
as reminder / timetable  
4 ‘Talk to you about it in words you 
understand and give you a clear timetable 
so you know when to see them!’ 
 Label /container with space 
to write on 
2 ‘Tell me why I’m taking it. Make sure the 
label on the bottle says how to take it. 
Saying ‘as discussed’ doesn’t help.’ 
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Discussion 
The results of this study suggest that people are generally not receiving information that they can 
understand and retain. People were only being given basic information about when and how to take 
the medicine and not offered information about side effects or contraindications.  Participants had 
many recommendations about the information that would help them to understand how to take 
medications, such as easy-read leaflets and pictures / diagrams or videos. They also had advice 
about other things that health professionals could do, such as offer advice on healthy living and 
alternative medications.  The participants often wanted their carers or family members to be 
informed about their medications, but a key theme from the results was that they wanted to be 
involved directly in the consultations.  
Most of the respondents recommended easy-read information and information with pictures. Easy 
read leaflets or labels have been found to improve knowledge of health information (psychology, 
primary care and prescription information) in some studies (Hurtado et al., 2014, Ziviani et al., 2004, 
Wolf et al., 2006).  However, in a randomized controlled trial of psychotropic medication information 
leaflets for people with learning disabilities, Strydom and Hall (2001) found that the leaflets did not 
significantly improve any aspect of medication knowledge. They proposed that this may have been 
due to health professionals relying on the leaflets as the only information source without offering 
sufficient verbal information. Further, accessible communication depends on the individual; easy-
read information is not always accessible to all people with learning disabilities and it is important to 
take individual needs into account. Some easy-read material may leave out important details in the 
quest for simplicity, such as contra-indications or the patient’s right to opt out of treatment (Chinn 
and Homeyard, 2016). Alternatives to easy-read leaflets are visual or audio formats, however some 
of our participants reported that they found it difficult to remember verbal information.  Therefore, 
we propose that offering easy-read and pictorial information to take home along with signposts to 
other mediums (such as apps, DVDs etc) should be combined with verbal information in a 
consultation that is tailored to the person. Adapted health information has a better chance of 
making an impact when it is tailored to an individual's individual requirements (Chinn and 
Homeyard, 2016). Further, it is important that the resources should be co-produced with people 
with learning disabilities who are more likely to have experienced the insufficiency of health 
information as described in this study and the wider literature (Ward and Townsley, 2005). Strydom 
and Hall (2001) advised that rather than excluding people with learning disabilities from the 
resources available, carers and health professionals should assist them to use the resources and help 
them to align new knowledge with previous knowledge. This suggests that appointment windows 
should be extended in order that there is time to do this (Jubraj et al., 2016a).  We agree with Heslop 
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et al. (2005), who recommend that professionals have time to spend on key facts, having accessible 
information available which is kept up-to-date, and training about medication for carers.  
Most of the participants in the current study did not recall receiving enough information about their 
medication, including side effects. It is possible that health professionals do not want to provide an 
overwhelming amount of information. McGrath (1999) reported that prescribers preferred two-way 
interactions focusing on the specific needs of the patient, rather than simply disseminating more and 
more information about the prescription. However, the prescribers in McGrath’s study tended to 
weigh up the benefits of providing full drug information against the potential of anxiety about 
possible side-effects, suggesting that paternalistic decisions are made about what information to 
include with all patients. Further, Ziegler et al. (2001) found that people without learning disabilities 
generally want more information from their prescribers, with those with lower levels of education 
requiring more than others. Llewellyn-Jones et al (2001) revealed that few general patients pose 
questions to their psychiatrist, reflecting the difficulties that patients had in discussing their 
symptoms and their medication. They concluded that patients may fear being judged if they say too 
much or they may be worried about the trivialisation of their concerns. This illustrates the need for 
objective information as well as tailored interaction in order to support informed consent. 
The question of who provides this information is an important consideration. In the present study, 
most of the people said they received information from their GP. People with learning disabilities are 
often invisible to pharmacists (Flood and Henman, 2010) as carers or staff often pick up the 
medications. However, some of our respondents pointed out that the GP and pharmacists talked to 
their carer or family member and not them, even when they were present. Participants in other 
studies also have commented on this (Jubraj et al., 2016b, The Disability Partnership, 2016). We 
argue that pharmacy consultations should be in-depth and tailored to the person’s communication 
style and ability (Dickinson et al., 2013). Furthermore, GPs, nurses and pharmacists should work 
together to share information about patients’ requirements and provide person centred care (Blasi 
et al., 2006). 
The respondents in this study reported that they wanted access to resources that they could 
understand and refer back to. In terms of access to resources, there have been a number of 
movements towards providing assistance with reasonable adjustments. For example:  
 The Learning Disabilities Observatory surveyed NHS trusts to find out what is provided 
(Hatton et al., 2011) and from this, Turner and Robinson (2011) produced resources for 
professionals and service-users about their right to expect reasonable adjustments.  
12 
 
 The organisation Change have worked with self-advocates to produce an easy-read guide to 
the Accessible Information Standard (Change, 2016).  
 The Medication Matters project (Norah Fry Centre, 2004) produced:  
o a checklist of things to ask the doctor about medication which can be used by people 
with learning difficulties, their families and carers,  
o a booklet for people with learning difficulties, their families or carers where they can 
record information about their medications, 
o an interactive decision making tool for people with learning difficulties to help them 
make informed choices about taking the medications they are prescribed 
o a guide for prescribers of psychotropic medications to things they should consider 
when issuing a prescription for psychotropic medication to people with learning 
difficulties  
o and a list of sources of information about medications. 
 Some agencies have designed accessible and easy read proformas and leaflets which cover 
health issues (Norah Fry Centre, 2004), videos about health (easyhealth.org.uk) and easy-
read psychoactive medication leaflets and audio downloads 
(birmingham.ac.uk/research/activity/ld-medication-guide/index.aspx and cwp.nhs.uk) many 
of which are collated in one BILD website (bild.org.uk/easyread/).  
 Others have developed decision making tools for patients (The Disability Partnership, 2016) 
and communication aid resources which can be used two-way to discuss health information 
(Dodd and Brunker, 1999, Heslop et al., 2004).  
 Creative strategies have been devised to improve two way communication such as the use 
of Health Passports (Disability Partnership, 2016), training service users to evaluate and 
review health services (Campbell and Martin, 2010) and employing service users to train 
pharmacists in how to communicate effectively (Donnelly, 2013).  
 Jubraj et al. (2016b) recommend the use of ‘My Medication Passport’ as focus groups in 
their study felt that this was a useful tool.  
These resources are all designed to help with accessible information provision to people with 
learning disabilities. Despite this wealth of available resources, the participants in the present study 
were not getting the information they needed. This could be due to lack of knowledge or awareness 
of the resources, or a lack of a centralised, approved space where they are stored.  Further, most of 
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the easy-read information available does not concern specific medications and this is what this study 
highlights as a crucial gap.  
There are limitations to this study. It should be noted that the sample of self-advocates is not 
representative of people with learning disabilities; it is a convenience sample only. A sample taken 
from a group of self-advocates may have a higher ability and/or skill level than a sample of people 
with learning disabilities taken from the general population. Further, the people who chose to 
complete a questionnaire may have been those with higher literacy levels than others at the 
conference.  Therefore, the results of this study should not be taken as generaliseable. 
Conclusion 
A key finding of this study, consistent with other studies, is that health professionals tend to talk to 
carers or family members rather than the individual themselves. This could be due to lack of skills 
and knowledge and could be addressed through training for GPs and pharmacists on eliciting and 
providing information to individuals with communication needs.  The diverse responses and 
recommendations we received demonstrate the wide range of accessibility requirements; health 
professionals should develop skills and systems to tailor their information to the person and be 
willing to provide information in more than one format (such as verbal and easy-read). 
Another key finding was that not all professionals spend the time to explain conditions and 
medications to people with learning disabilities. We recommend that extra appointment time should 
be allotted to working with people with accessibility needs, that professionals should spend the time 
early on to get to know the individual and their requirements, and this will compensate in later 
appointments.  
This study also demonstrates the lack of knowledge about available resources for people with 
learning disabilities. Future research should focus on the implications of not being provided with 
health information that is accessible, in particular the issue of polypharmacy and the difficulties of 
retaining information and knowledge regarding multiple medications. Future research could explore 
the viability of providing a centralised system, connected electronically to GP and pharmacist 
information systems. This sort of resource, along with person centred consultations with both GP 
and pharmacy staff, would allow greater access to the information people need to make informed 
decisions about their medications, and better knowledge of how to use them. 
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